A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial

OBJECTIVE: To determine the safety and efficacy of dose-dense (dd) paclitaxel (PTX) and carboplatin (CBDCA) in treating advanced or recurrent endometrial cancer. METHODS: Women aged 20–75 years with histologically confirmed endometrial cancer, the International Federation of Gynecology and Obstetric...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Kensuke, Nishio, Shin, Ushijima, Kimio, Kasamatsu, Yuka, Kondo, Eiji, Takehara, Kazuhiro, Ito, Kimihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192238/
https://www.ncbi.nlm.nih.gov/pubmed/34085798
http://dx.doi.org/10.3802/jgo.2021.32.e64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192238/
https://www.ncbi.nlm.nih.gov/pubmed/34085798
http://dx.doi.org/10.3802/jgo.2021.32.e64

Ejemplares similares